MA50039A - Programme de dosage pour tésétaxel et capécitabine - Google Patents

Programme de dosage pour tésétaxel et capécitabine

Info

Publication number
MA50039A
MA50039A MA050039A MA50039A MA50039A MA 50039 A MA50039 A MA 50039A MA 050039 A MA050039 A MA 050039A MA 50039 A MA50039 A MA 50039A MA 50039 A MA50039 A MA 50039A
Authority
MA
Morocco
Prior art keywords
tesetaxel
capecitabine
dosage schedule
schedule
dosage
Prior art date
Application number
MA050039A
Other languages
English (en)
Inventor
Stew Kroll
John G Lemkey
Steven Pfeiffer
Kevin Tang
Jeff Vacirca
Thomas Wei
Original Assignee
Odonate Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Odonate Therapeutics Inc filed Critical Odonate Therapeutics Inc
Publication of MA50039A publication Critical patent/MA50039A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
MA050039A 2017-06-02 2018-06-01 Programme de dosage pour tésétaxel et capécitabine MA50039A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762514483P 2017-06-02 2017-06-02

Publications (1)

Publication Number Publication Date
MA50039A true MA50039A (fr) 2020-07-08

Family

ID=64455637

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050039A MA50039A (fr) 2017-06-02 2018-06-01 Programme de dosage pour tésétaxel et capécitabine

Country Status (14)

Country Link
US (1) US20200179427A1 (fr)
EP (1) EP3630091A4 (fr)
JP (1) JP2020522568A (fr)
KR (1) KR20200014880A (fr)
CN (1) CN111032035A (fr)
AU (1) AU2018275122A1 (fr)
BR (1) BR112019025164A2 (fr)
CA (1) CA3065783A1 (fr)
EA (1) EA201992852A1 (fr)
IL (1) IL270973A (fr)
MA (1) MA50039A (fr)
MX (1) MX2019014489A (fr)
TW (1) TW201902473A (fr)
WO (1) WO2018223029A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022505222A (ja) * 2018-10-17 2022-01-14 オドネイト セラピューティクス，インコーポレーテッド テセタキセルを用いてｃｎｓ腫瘍を治療する方法
TW202112364A (zh) * 2019-08-16 2021-04-01 美商蜻蛉治療股份有限公司 投與替司他賽(tesetaxel)與cyp3a4誘導劑之糖皮質素之方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016168451A1 (fr) * 2015-04-14 2016-10-20 Merrimack Pharmaceuticals, Inc. Compositions pour l'amélioration de la pharmacocinétique et de l'indice thérapeutique d'un traitement du cancer

Also Published As

Publication number Publication date
KR20200014880A (ko) 2020-02-11
CA3065783A1 (fr) 2018-12-06
TW201902473A (zh) 2019-01-16
BR112019025164A2 (pt) 2020-06-16
IL270973A (en) 2020-01-30
EA201992852A1 (ru) 2020-03-27
AU2018275122A1 (en) 2019-12-19
JP2020522568A (ja) 2020-07-30
MX2019014489A (es) 2020-08-17
CN111032035A (zh) 2020-04-17
EP3630091A4 (fr) 2021-03-10
WO2018223029A1 (fr) 2018-12-06
US20200179427A1 (en) 2020-06-11
EP3630091A1 (fr) 2020-04-08

Similar Documents

Publication Publication Date Title
ZA201902533B (en) Anti-pd-l1 antibodies and variants
DK3368572T3 (da) Anti-pd-1-antistoffer og -sammensætninger
ES2966890T3 (es) Nuevos anticuerpos anti-PD-L1
IL258187A (en) Devices and methods for analyzing animal behavior
ES2719132R1 (es) Procedimiento y dispositivo para procesar señales de vídeo
MA52814A (fr) Inhibiteurs de bromodomaine
IL271222A (en) Dosing regimens for anti-tim-3 antibodies and their uses
KR20180084959A (ko) 파면 분석을 위한 디바이스 및 방법
DK3672948T3 (da) Pyridinamin-pyridon- og pyrimidinamin-pyridonforbindelser
GB201708624D0 (en) System for evaluating dosage parameters
MA50039A (fr) Programme de dosage pour tésétaxel et capécitabine
DK3641919T3 (da) Doseringsanordning
GB201807801D0 (en) Microparticles
IL273351A (en) antibody variants
FR3032925B1 (fr) Generation et traitement deporte de photometrie
DK3456736T3 (da) Antistofvarianter
IT201700055422A1 (it) Impianto dosatore
IL272951A (en) antibody variants
DK3672967T3 (da) Azaindolylpyridon- og diazaindolylpyridonforbindelser
SG10202100683RA (en) Monoclonal antibody against melk and utilization thereof
NO20170618A1 (no) Fortøyningsplate for oppdrettsanlegg
FR3044649B1 (fr) Distributeur de couverts
FI20150191A (fi) Menetelmä suojuksen automaattiseksi avaamiseksi ja suojuskokoonpano
FR3036947B1 (fr) Dispositif de remplissage de paillettes et machine le comportant
GB2578024B (en) Animal bridge